Phase 3
Completed N=185
Patient Narcotic Requirements After Outpatient Otolaryngology Procedures
Outpatient Surgery · Pain, Postoperative
Source: ClinicalTrials.gov NCT03404518 ↗
Enrolled (actual)
185
Serious AEs
0.0%
Results posted
Mar 2022
Primary outcomePrimary: Narcotic Usage — 4.9; 2.0 Pills
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Patient's pain level and narcotic requirements will be evaluated after routine outpatient Otolaryngology procedures. This will be done by having study participants record their pain level and medication usage from home.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Narcotic Usage |
4.9; 2.0 | — |
| SECONDARY Patient Pain Level |
3.5; 2.8 | — |
| SECONDARY Ibuprofen Usage |
4.5; 7.7 | — |
Eligibility Criteria
Inclusion Criteria
Patients undergoing one of the following outpatient procedure:
- Septoplasty
- Unilateral or Bilateral Functional endoscopic sinus surgery
- Tympanomastoidectomy
- Tympanoplasty
- Total or Partial Thyroidectomy
- Parathyroidectomy
- Parotidectomy.
- Age >18 years and 89 years
- Post operative hospital admission
- Allergy to Hydrocodone
- Allergy or contraindication to Ibuprofen or NSAIDs
- Pregnancy
- Hepatic disease
- Chronic kidney disease
- Sickle cell anemia
Data sourced from ClinicalTrials.gov (NCT03404518). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.